Lenalid 25mg Capsules

Lenalid 25mg Capsules contain lenalidomide, an immunomodulatory medicine used in the management of certain blood cancers and related haematological conditions. Lenalidomide is prescribed by specialist healthcare professionals as part of carefully monitored treatment protocols. Its use, dosage and treatment duration depend on the patient's diagnosis, clinical condition and applicable prescribing guidelines.

What Are Lenalid 25mg Capsules?

Lenalid 25mg Capsules are an oral formulation containing 25 mg of lenalidomide as the active pharmaceutical ingredient. Lenalidomide belongs to a class of medicines known as immunomodulatory agents. It influences immune system activity and affects processes involved in the growth and survival of certain abnormal blood cells.

The 25 mg strength is used in specific treatment protocols under specialist supervision. The appropriate formulation and strength must be determined by the treating oncologist or haematologist.

Lenalid 25mg Uses and Therapeutic Applications

Lenalidomide is used in selected haematological conditions, depending on the approved product label and applicable regulatory indications.

Its established therapeutic applications include:

Multiple Myeloma: Used in combination with other prescribed medicines, including dexamethasone, for eligible patients with multiple myeloma.

Myelodysplastic Syndromes (MDS): Used in selected patients with transfusion-dependent anaemia associated with deletion 5q cytogenetic abnormalities.

Other Approved Indications: Certain lenalidomide products have additional specialist indications, depending on the country's regulatory approval and prescribing information.

Treatment selection must be based on the patient's diagnosis, laboratory findings and specialist assessment. Lenalidomide is not suitable for every patient with these conditions.

How Does Lenalidomide Work?

Lenalidomide has immunomodulatory and antineoplastic properties. It interacts with cereblon, a component of an E3 ubiquitin ligase complex, influencing the degradation of specific proteins involved in abnormal cell activity.

Its pharmacological actions include modifying immune responses, affecting tumour-cell survival and influencing the bone marrow microenvironment. These mechanisms contribute to its therapeutic role in selected haematological malignancies.

Important Safety Information and Precautions

Lenalidomide requires strict medical supervision because it can cause serious adverse reactions.

Pregnancy Risk: Lenalidomide can cause severe, life-threatening birth defects. It is contraindicated during pregnancy and requires strict pregnancy-prevention measures.

Blood Disorders: Treatment may cause neutropenia, thrombocytopenia and anaemia. Regular blood count monitoring is essential.

Blood Clots: Patients may have an increased risk of venous thromboembolism and arterial thrombotic events.

Kidney Function: Dosage adjustments may be necessary in patients with impaired renal function.

Other Adverse Effects: Fatigue, diarrhoea, constipation, rash and infections may occur.

Patients must follow the prescribing specialist's instructions and undergo recommended laboratory monitoring. Never start, stop or modify treatment without medical advice.

Storage and Handling

Store Lenalid 25mg Capsules according to the manufacturer's approved packaging instructions. Keep the medicine in its original packaging, away from children and unauthorised access. Do not open, break or handle damaged capsules. Follow appropriate pharmaceutical handling and disposal procedures.

Pharmaceutical Supply Information – Cordium Pharmaceuticals Pvt. Ltd.

Cordium Pharmaceuticals Pvt. Ltd. provides pharmaceutical product information and supports appropriate business enquiries relating to pharmaceutical sourcing and supply. Enquiries concerning Lenalid 25mg Capsules should be handled in accordance with applicable pharmaceutical regulations, prescription requirements and authorised distribution practices.

Product availability, manufacturer details, packaging, batch information and regulatory documentation should be independently verified before procurement. This product is intended for regulated pharmaceutical channels and is not promoted for unsupervised patient use.

Frequently Asked Questions

1. What is the active ingredient in Lenalid 25mg Capsules?

The active ingredient is lenalidomide, an immunomodulatory medicine used in selected haematological conditions.

2. Is Lenalid 25mg a prescription medicine?

Yes. Lenalidomide requires specialist prescription and medical monitoring.

3. Can Lenalid 25mg Capsules be used during pregnancy?

No. Lenalidomide is contraindicated during pregnancy because of its serious risk of causing birth defects.

4. Does Lenalidomide require regular monitoring?

Yes. Blood counts, kidney function and other relevant clinical parameters require monitoring as directed by the treating specialist.